Whalesbook
KIMS Hospital Secures 20-Year Management Deal for Kerala Facility
Krishna Institute of Medical Sciences Ltd (KIMS) announced that its wholly-owned subsidiary, KIMS Swastha, has signed a 20-year definitive agreement to manage Avitis Super Speciality Hospitals' 210-bed facility in Palakkad, Kerala.
The agreement, effective April 2, 2026, includes substantial security deposits totaling ₹29.75 crore and a revenue-sharing model.
Key Details of the Agreement
Under the terms, KIMS Swastha will manage, operate, and sub-lease the Palakkad hospital. The financial commitments include an Operations and Management (O&M) security deposit of ₹29.75 crore, with ₹5 crore retained by Avitis, and a ₹0.25 crore sub-lease security deposit.
Monthly O&M fees are set at ₹10 lakh for the first 12 months, increasing to ₹25 lakh afterward. Revenue fees will be the higher of a minimum monthly guarantee of ₹22 lakh or 4% of total Net Revenues, which includes a ₹3 lakh sub-lease rent.
Crucially, the agreement grants KIMS Swastha a call option, giving it the right, but not the obligation, to acquire a majority shareholding in Avitis at its discretion.
Strategic Expansion Through Asset-Light Model
This move signifies KIMS Hospitals' accelerated expansion into the Kerala market using an 'asset-light' operational model. This strategy allows the company to gain significant operational control and brand presence without the immediate capital burden of outright ownership.
The 20-year tenure provides long-term stability, while the call option offers a flexible path to potentially consolidate ownership in the future if it proves strategically beneficial.
KIMS's Growing Kerala Footprint
KIMS Hospitals has been actively building its presence in Kerala. The company has previously entered into operations and management (O&M) contracts with Sreechand Hospital in Kannur and Westfort Hospital in Thrissur. Further development is also underway at the latter.
The group has ambitious plans for Kerala, aiming to acquire 3,000 beds over the next five years and establish large 'health cities' in Kochi and Kozhikode. This latest agreement aligns with KIMS's preference for an 'asset-light model' to drive growth.
Key Changes and Future Possibilities
KIMS gains operational control and management of a 210-bed super specialty hospital in Palakkad. This agreement significantly expands KIMS's geographical footprint and brand reach within Kerala. The asset-light approach facilitates expansion with manageable upfront capital expenditure, and the future call option provides strategic flexibility for majority ownership.
Potential Risks to Monitor
Investors should note several potential risks. The financial performance of the Avitis hospital might not meet the minimum revenue guarantee or the 4% net revenue threshold, impacting KIMS's profitability. The call option is discretionary, meaning KIMS is not obligated to acquire the stake even if it becomes strategically advantageous.
Additionally, KIMS's subsidiary, SPANV Medisearch Lifesciences Private Ltd, previously received an Income Tax demand notice of ₹306.97 crore for assessment year 2022-23; KIMS had clarified SPANV was not its subsidiary for that specific assessment year. The company has also faced past consumer court cases alleging medical negligence, with some resulting in compensation orders against KIMS and its doctors.
Peer Comparison in Hospital Expansion
KIMS's strategy of expanding into Kerala via an O&M agreement and sub-lease reflects a broader industry trend among hospital chains seeking growth. Competitors like Apollo Hospitals, Fortis Healthcare, and Max Healthcare are also aggressively expanding, often through significant investments in brownfield expansions, selective acquisitions, and new greenfield projects. While others might focus more on direct ownership, KIMS's adoption of an asset-light model for this venture highlights a varied approach to market entry and capacity building.
Key Metrics and Timeline
- Agreement Period: 20 years (effective from April 2, 2026).
- Total O&M Security Deposit: ₹29.75 crore.
- Monthly O&M Fee: Starting at ₹10 lakh, increasing to ₹25 lakh after 12 months.
- Revenue Fees: Minimum guarantee of ₹22 lakh per month or 4% of total Net Revenues.
What to Watch Next
Key developments to monitor include the operational commencement of the Avitis hospital under KIMS's management on April 2, 2026. Investors will also watch KIMS's future decision on exercising the call option for majority stake acquisition in Avitis and track the hospital's financial performance against the stipulated revenue guarantees. Any further expansion announcements from KIMS in Kerala or other regions will also be of interest.